Dare Bioscience Inc

NASDAQ:DARE  
1.35
+0.02 (+1.50%)
Earnings Announcements

Daré Bioscience Reports Q3 Loss Per Share $0.24

Published: 11/12/2020 13:39 GMT
Dare Bioscience Inc (DARE) - DarÉ Bioscience Reports Third Quarter 2020 Financial Results and Provides Company Update.
Qtrly Loss per Share $0.24.
Cash and Cash Equivalents Were Approximately $5.4 Million at September 30, 2020.
Q3 Earnings per Share View $-0.17 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.65 Million
Adjusted EPS is expected to be -$0.13

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.20

More details on our Analysts Page.